Table E3.
Outcome | Estimate | SE | z Value | P |
---|---|---|---|---|
Hospitalization | ||||
X | –0.646 | 0.066 | –9.841 | <2e-16 |
X′ | 0.514 | 0.070 | 7.311 | 2.6e-13 |
Intensive care unit admission | ||||
X | –0.500 | 0.110 | –4.524 | 6.1e-06 |
X′ | 0.383 | 0.118 | 3.255 | 0.001 |
Died | ||||
X | –0.784 | 0.130 | –6.035 | 1.6e-09 |
X′ | 0.599 | 0.142 | 4.222 | 2.4e-5 |
Medications in the model include nonsteroidal anti-inflammatory drugs, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, inhaled corticosteroids, intranasal corticosteroids, and immunosuppressive therapy that includes systemic corticosteroids). Comorbidities in the model include diabetes, hypertension, coronary artery disease, heart failure and cancer (historical or current), immunosuppressive diseases, and connective tissue diseases.
Adjusted for demographics, body mass index, smoking, medications, comorbidities, and the month of testing.